(18F)AV-133

Known as: 18F-AV-133, Fluorine F 18-AV-133 
A radioconjugate composed of the vesicular monoamine transporter 2 (VMAT2) targeting agent AV-133, a dihydrotetrabenazine analog, labeled with the… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2010-2017
01220102017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Idiopathic Parkinson disease is a common neurodegenerative disorder for which misdiagnosis occurs in up to 30% of patients after… (More)
Is this relevant?
2015
2015
Recent experimental studies revealed that dopamine neuron dysfunction in chronic manganism may be due to a reduced capacity of… (More)
Is this relevant?
2014
2014
BACKGROUND Biomarkers based on the underlying pathology of Alzheimer's disease (AD) and Dementia with Lewy Bodies (DLB) have the… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2014
2014
Imaging targeting vesicular monoamine transporter (VMAT2) alterations is a sensitive tool for early diagnosis of Parkinson’s… (More)
  • figure 1
  • figure 2
  • figure 3
  • table I
  • figure 4
Is this relevant?
2011
2011
UNLABELLED (18)F-9-fluoropropyl-(+)-dihydrotetrabenazine ((18)F-AV-133) is a novel positron emission tomography tracer for… (More)
Is this relevant?
2010
2010
UNLABELLED Vesicular monoamine transporter 2 (VMAT2) is highly expressed in the endocrine cells and brain. We investigated the… (More)
Is this relevant?